Crossingbridge Advisors’s Vendome Acquisition Corp I VNME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1M Buy
993,758
+105,023
+12% +$1.07M 1.79% 14
2026
Q1
$8.96M Buy
888,735
+513,735
+137% +$5.18M 1.62% 21
2025
Q4
$3.76M Sell
375,000
-100,000
-21% -$1M 1.06% 24
2025
Q3
$4.72M Buy
+475,000
New +$4.71M 2.41% 12

Other funds holding VNME

Crossingbridge Advisors's VNME Position: Q2 2026 in Review

Crossingbridge Advisors increased its Vendome Acquisition Corp I (VNME) stake by 12% in Q2 2026, buying an estimated $1.07M and bringing the position to 993,758 shares worth $10.1M. The position accounts for 1.79% of the portfolio, ranked #14.

Crossingbridge Advisors first reported a position in VNME in Q3 2025 and has held it in 4 quarters since. 42 funds tracked by Wall St. Rank hold VNME as of Q2 2026.

  • Crossingbridge Advisors held 993,758 shares of Vendome Acquisition Corp I worth $10.1M as of Q2 2026.
  • Crossingbridge Advisors bought 105,023 Vendome Acquisition Corp I shares in Q2 2026, an estimated $1.07M.
  • Vendome Acquisition Corp I made up 1.79% of Crossingbridge Advisors's portfolio in Q2 2026, its #14 holding.
  • Crossingbridge Advisors first reported a position in Vendome Acquisition Corp I in Q3 2025 and has held it in 4 quarters since.
  • 42 funds tracked by Wall St. Rank held Vendome Acquisition Corp I as of Q2 2026.

Based on Crossingbridge Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.